Prestige Biologics Co., Ltd.

KOSDAQ:A334970 Stock Report

Market Cap: ₩361.6b

Prestige Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of A334970?
Owner TypeNumber of SharesOwnership Percentage
Institutions13,8750.0226%
Private Companies6,011,5989.77%
Public Companies15,206,56024.7%
Individual Insiders15,979,59526%
General Public24,289,84139.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 14 shareholders own 60.51% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
24.7%
Prestige BioPharma Limited
15,206,560₩89.4b0%no data
12.7%
So-Yeon Park
7,807,821₩45.9b0%no data
12.5%
Jinwoo Kim
7,711,601₩45.3b0%no data
5.28%
Octava Fund Limited
3,248,584₩19.1b0%no data
3.2%
Plousios Bio No. 1 Co., Ltd.
1,970,163₩11.6b0%no data
1.29%
Plousios Bio No. 2 Co., Ltd.
792,851₩4.7b0%no data
0.44%
Joon-young Gwak
270,970₩1.6b0%no data
0.13%
Hyuncheol Dong
80,000₩470.4m0%no data
0.073%
Jae-Yeong Yang
45,000₩264.6m0%no data
0.045%
Deok-hun Hyeon
27,962₩164.4m0%no data
0.03%
Youngsu Lim
18,449₩108.5m0%no data
0.026%
Lai Way Tay
15,792₩92.9m0%no data
0.023%
State Street Global Advisors, Inc.
13,875₩81.6m1.54%no data
0.0032%
Seok-jae Seo
2,000₩11.8m0%no data